Pivotal bioVenture Partners Fund I, L.P. - Director at Inozyme Pharma, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
INZY
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Pivotal bioVenture Partners Fund I, L.P. since 14 Aug 2025

Reported holdings for Pivotal bioVenture Partners Fund I, L.P. in Inozyme Pharma, Inc.

Form 4 holding Director

Inozyme Pharma, Inc.

Security class
Common Stock
Shares / value
1,571,741
Estimated value
$5,611,115
Report date
01 Aug 2023
Price
$3.57
Ownership
Indirect

Transaction history for Pivotal bioVenture Partners Fund I, L.P. in Inozyme Pharma, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .